Amesite Inc. plans to conduct a public offering of common stock, subject to market conditions.
Quiver AI Summary
Amesite Inc. has announced its intention to conduct a public offering of shares of common stock or pre-funded warrants in a “best efforts” underwritten offering, with no guarantee on the timing or size of the offering. The company plans to use the proceeds for general corporate purposes, including capital expenditures and working capital, and has engaged Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC as joint book-running managers. A registration statement for this offering has been filed with the SEC and was declared effective in December 2024. While preliminary documents will be made available, this announcement does not constitute an offer to sell the securities, which will be made only through the prospectus supplement. Amesite specializes in AI-driven solutions for both businesses and consumers, notably through its NurseMagic™ app, aimed at supporting health and care professionals.
Potential Positives
- The company is pursuing a public offering, which could provide necessary capital for growth and operational expenses.
- The successful completion of the offering could enhance the company’s financial stability and support future business initiatives.
- Amesite Inc. is leveraging its proprietary AI infrastructure, indicating a focus on innovative technology solutions that could capture market interest and drive revenue.
- The involvement of established financial firms as joint book-running managers adds credibility to the offering process.
Potential Negatives
- The press release indicates that the public offering is subject to market and other conditions, implying uncertainty around its completion, which may affect investor confidence.
- The use of the term "best efforts" suggests that the company is relying on the underwriters to sell the shares, which could reflect an inability to attract demand on its own.
- The mention of using proceeds for "general corporate purposes" and "general and administrative expenses" may raise concerns among investors about the company's financial health and specific growth strategies.
FAQ
What is Amesite Inc. planning to offer?
Amesite Inc. plans to offer and sell shares of its common stock or pre-funded warrants in an underwritten public offering.
Who are the joint book-running managers for the offering?
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are acting as joint book-running managers for the offering.
What will Amesite use the proceeds from the offering for?
The proceeds will be used for general corporate purposes, capital expenditures, working capital, and general administrative expenses.
Where can I access the preliminary prospectus for the offering?
The preliminary prospectus will be filed with the SEC and available on their website at www.sec.gov.
What does this press release not constitute?
This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities mentioned.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AMST Hedge Fund Activity
We have seen 4 institutional investors add shares of $AMST stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 12,143 shares (-100.0%) from their portfolio in Q3 2024
- JPMORGAN CHASE & CO added 5,904 shares (+inf%) to their portfolio in Q3 2024
- UBS GROUP AG added 914 shares (+167.1%) to their portfolio in Q3 2024
- TOWER RESEARCH CAPITAL LLC (TRC) removed 649 shares (-53.9%) from their portfolio in Q3 2024
- GEODE CAPITAL MANAGEMENT, LLC added 376 shares (+2.7%) to their portfolio in Q3 2024
- BANK OF AMERICA CORP /DE/ added 1 shares (+0.6%) to their portfolio in Q3 2024
- ZUCKERMAN INVESTMENT GROUP, LLC added 0 shares (+0.0%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Amesite Inc . (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a “best efforts” underwritten public offering. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are acting as joint book-running managers for the offering.
The Company intends to use the net proceeds from the offering for [general corporate purposes, capital expenditures, working capital and general and administrative expenses].
A shelf registration statement on Form S-3 (Registration No. 333-282999) relating to the public offering of the securities described above was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the proposed underwritten public offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the preliminary prospectus supplement (when available) and accompanying prospectus relating to the offering may be obtained from Laidlaw & Company (UK) Ltd., 521 Fifth Ave., 12 th Floor, New York, NY 10175, Attention: Syndicate Dept.; email: [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s anticipated public offering, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
[email protected]